Latest

Revvity presented their diverse portfolio of cancer research tools at AACR, reaffirming their commitment to empowering researchers

The RNA-based strategy targets a part of the viral genome that is common to all strains of a virus, potentially eliminating the need for seasonal boosters

New findings suggest pathway for screening high-risk individuals for pancreatic cancer in PRECEDE study

What’s driving stress and burnout in the clinical lab—and how can the pressure be relieved?

New study suggests the placenta is a key factor in the development of gestational diabetes

“Jaw dropping” findings suggest there are yet undiscovered mechanisms for telomere length regulation, offering hope for treating cancer and degenerative disease

New CRO system-level expansion elevates data stewardship and enables organizations to gain more insight with less oversight

Treatment for lung condition could help patients with SCD control complications from hypertension and kidney damage

First genome-wide association study finds variants linked to susceptibility of cervical cancer-causing virus

Integrating epigenetic insights into cancer research could help deliver personalized, high-quality, and cost-effective patient care

The findings shed light on how sugar molecules in the blood of people living with HIV may have pro-inflammatory effects

Each of us has natural, valuable gifts we can use to grow our success and sense of professional fulfillment

The new screening method in trials includes two blood tests and an MRI scan of the prostate, if necessary

Saruparib has higher selectivity for PARP1, improving safety and tolerability compared to existing first-gen PARP inhibitors

The preservative reagent in Protein Plus BCT™ maintains sample integrity during storage, shipping, and handling